Corporate Symposia - non–CME


Meeting the Challenges of Alzheimer’s Disease: Commitment and Collaboration on the Road to Transformation

Monday, July 23 | 12:15 p.m. – 1:45 p.m.

Hyatt Regency McCormick Place, Regency Ballroom A and B

Disease-modifying therapies. Biomarkers driving early diagnosis. Making a difference for patients and caregivers. Working towards transformations like these in Alzheimer’s disease demands a cohesive network of leading clinical, academic, and industry perspectives to illuminate the path forward. Join us to see where this scientific journey may lead.

Sponsored by: Genentech



The Early Diagnosis of Alzheimer’s Disease: Exploring a Patient with Memory Complaints and Identifying Underlying Pathologies

Monday, July 23 | 6 p.m. – 9 p.m. (Dinner will be served from 6- 6:30 p.m.)

Marriott Marquis Hotel, Great Lakes Ballroom ABC

Join our eminent faculty for an engaging and interactive case-based discussion that will explore a patient with mild cognitive impairment and their journey to reaching a diagnosis. This non-CME symposium promises to engage the audience and stimulate discussions around a challenging case with underlying pathology.

Sponsored by: Biogen



Controversies in Preclinical Alzheimer’s Disease: Risk Factors, Biomarkers and Reimbursement

Monday, July 23 | 6:30 p.m. – 8:00 p.m.

Marriott Marquis Chicago, Grand Horizon Ballroom 1,2,3, Level 4

Recent scientific advances have opened up possibilities for better understanding Alzheimer’s disease in the preclinical stage, before the onset of clinical symptoms. This symposium will address the opportunities, challenges and areas of current debate that accompany this new era of research; and implications for individuals at risk for Alzheimer’s disease.

Sponsored by: Amgen Novartis

Data on file USA-CBU-80107, M-NPD-1360547 6/18



Facing Down Alzheimer’s

Tuesday, July 24 | 6 p.m. – 9 p.m.

Marriott Marquis Hotel, Grand Ballroom 1-14

We at AbbVie aspire to make a remarkable impact for patients and families affected by Alzheimer’s disease through the development of transformational treatments. We’ve committed ourselves and our pipeline to facing down Alzheimer’s. Please join us as we come together with our community, leading scientists and technologists to Dream, Defy and Disrupt Alzheimer’s Disease.

Sponsored by: AbbVie



Thinking Globally About Alzheimer’s Disease

Tuesday, July 24 | 6:00 p.m. – 8:00 p.m.

Hyatt Regency McCormick Place, Regency Ballroom A and B

Join Eisai for an interactive symposium titled, “Thinking Globally About Alzheimer’s Disease”. A diverse panel of experts will discuss the global nature of clinical trials and evaluate global readiness to screen, diagnose, and treat Alzheimer’s disease as the paradigm shifts towards initiating treatment earlier in the disease course.

Sponsored by: Eisai



Detecting AD with Plasma Biomarkers: Innovations That Inform Clinical Practice

Wednesday, July 25 | 6 p.m. – 8:15 p.m.

Marriott Marquis Hotel, Great Lakes Ballroom ABC

This symposium will focus on the dynamic changes and progress taking place in the field of assaying plasma biomarkers for Alzheimer’s disease (AD) and other neurodegenerative disorders. Learn what the IMR-SQUID platform is, and why this innovative technology has the potential to both inform and transform clinical care.

Sponsored by: MagQu Co, Ltd

Join the Conversation #AAIC19






> 1200px
> 992px
> 768px
< 767px